Claussnitzer et al. in 2015 elucidated the underlying pathophysiological mechanisms associating FTO with obesity development by identifying its effect on the IRX3 gene promoter, located 0.5 MB downstream of FTO [132]. This evidence concerns the gene FTO and obesity disorder.